EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Heterogeneity of Lung Cancer: The Histopathological Diversity and Tumour Classification in the Artificial Intelligence Era

Raquel Ramos, Conceição Souto Moura, Mariana Costa, Nuno Jorge Lamas, Lígia Prado E Castro, Renato Correia, Diogo Garcez, José Miguel Pereira, Carlos Sousa, Nuno Vale

Pathobiology · 14.04.2025 · 92 (4) · 239-250

DOI: 10.1159/000544892 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathobiology, online erschienen am 14.04.2025. Verfasst von Raquel Ramos und 9 weiteren Autor:innen. Beteiligte Einrichtung: PerMed Research Group, Center for Health Technology and Services Research (CINTESIS), Porto, Portugal. Hauptthemen laut MEDLINE: Lung Neoplasms, Artificial Intelligence, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Lung cancer is the most common cancer worldwide and is also the leading cause of cancer-related mortality. Its poor prognosis is primarily attributed to unspecific symptoms that result in late diagnosis, and its heterogeneous nature that further complicates treatment. This heterogeneity is largely driven by the diversity in histological subtypes, significantly impacting the clinical course of patients. Therefore, tumour subtyping using haematoxylin and eosin staining and immunohistochemistry is crucial for predicting patients’ outcomes, making an accurate diagnosis, and choosing the appropriate treatment approach. Small-cell lung cancer and non-small cell lung cancer are the two major types, and subclassifying non-small cell lung cancer is essential to identify genetic alterations and, consequently, choose an adequate targeted therapy. Summary: This article reviews all these lung tumour characteristics, specifying histological types and subtypes, and presenting their distinct features. To aid understanding, complementary images from Unilabs illustrate various lung tumour subtypes. Additionally, alternative approaches using artificial intelligence to improve tumour classification are reviewed, along with a discussion of their limitations. Key Messages: Thus, lung tumour classification is crucial for cancer treatment; nonetheless, it can be a subjective process, reliant on the pathologist’s interpretation. In the era of artificial intelligence and deep/machine learning, the classification of lung cancer subtypes has the potential to become more efficient, accurate, and consistent. These advancements could lead to faster diagnosis and treatment decisions, ultimately improving patient survival and quality of care. Harnessing AI tools may address the limitations of subjective interpretation, offering a promising avenue for enhancing precision in lung cancer diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsArtificial IntelligenceCarcinoma, Non-Small-Cell LungSmall Cell Lung CarcinomaHumansPrognosis

Stichwörter der Autor:innen

Artificial intelligenceHistopathologyLung cancerMachine learningMolecular subtypes

Autor:innen und Institutionen

  • PerMed Research Group, Center for Health Technology and Services Research (CINTESIS), Porto, Portugal.
  • CINTESIS@RISE, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Molecular Diagnostics Laboratory, Unilabs Portugal, Centro Empresarial Lionesa Porto, Leça do Balio, Portugal.
  • Pathology Laboratory, Unilabs Portugal, Porto, Portugal.
  • Anatomic Pathology Service, Pathology Department, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.
  • Life and Health Sciences Research Institute (ICVS), School of Medicine, Campus de Gualtar, University of Minho, Braga, Portugal.

Zitieren

APA

Ramos, R., Moura, C. S., Costa, M., Lamas, N. J., Castro, L. P. E., Correia, R., Garcez, D., Pereira, J. M., Sousa, C., & Vale, N. (2025). Heterogeneity of Lung Cancer: The Histopathological Diversity and Tumour Classification in the Artificial Intelligence Era. Pathobiology, 92(4), 239-250. https://doi.org/10.1159/000544892

Vancouver

Ramos R, Moura CS, Costa M, Lamas NJ, Castro LPE, Correia R, et al. Heterogeneity of Lung Cancer: The Histopathological Diversity and Tumour Classification in the Artificial Intelligence Era. Pathobiology. 2025;92(4):239-250. doi:10.1159/000544892

BibTeX
@article{Ramos2025,
  author = {Ramos, Raquel and Moura, Conceição Souto and Costa, Mariana and Lamas, Nuno Jorge and Castro, Lígia Prado E and Correia, Renato and Garcez, Diogo and Pereira, José Miguel and Sousa, Carlos and Vale, Nuno},
  title = {Heterogeneity of Lung Cancer: The Histopathological Diversity and Tumour Classification in the Artificial Intelligence Era},
  journal = {Pathobiology},
  year = {2025},
  volume = {92},
  number = {4},
  pages = {239--250},
  doi = {10.1159/000544892}
}
Kostenlos starten →